Angel Scale Biotech: Learn More
Richard Vlasimsky is using AI to create a low-cost way of vastly expanding our ability to detect lung cancer early. His algorithm for detecting lung nodules in chest x-rays just got FDA clearance. Listen to this remarkable founder who’s done a lot with modest funding.
Sponsored by Purdue University entrepreneurship and Peter Fasse, patent attorney at Fish and Richardson.
Highlights:
- Sal Daher Introduces Richard Vlasimsky
- What IMIDEX is Solving
- "... how much your studies cost to get your 510k.."
- "... We had multiple radiologists looking at the image, and then we had a final truther that adjudicated these independent reads that the radiologist did..."
- "... Payers care about catching it early so that they have better outcomes and the costs are much lower ... The providers, being the medical systems or the physicians, typically hospitals, they care about it because of liability issues and also because they could have the opportunity to treat something and they would get the revenue stream..."
- "... It's like a very fine-tooth comb picks up all the nits. The specificity relates to how many of those things that you pick up are actually what you're looking for and not false positives..."
- Exit Possibilities
- "... his definition of a startup is an enterprise that uses resources that it does not yet command..."
- Richard’s Entrepreneurial Journey
- "... You had this experience of joining a startup, then creating your own startup which was using machine learning..."
- Advice to the Audience
Topics: biotech, discovering entrepreneurship, robotics/AI, founding story
